TrialDiabetes care2014

Empagliflozin as add-on to metformin in patients with type 2 diabetes: a 24-week, randomized, double-blind, placebo-controlled trial.

Hans-Ulrich Häring et al.PubMed ↗Publisher ↗

No numbers read from the abstract.